Phase 3 Neurological impairment Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3Phase 4

Effect of prophylactic azithromycin on chest infections in children with neurological and neuromuscular impairment

Neurological impairment

Menzies School of Health Research94 enrolled2 locationsACTRN12621001486819

Recruiting

Phase 3

Joint UK and Australia multicentre, randomised, double blind, placebo controlled pragmatic trial comparing 52 weeks of azithromycin to placebo in children with neurological impairment at risk of lower respiratory tract infection (the PARROT trial).

Neurological impairment

University of Liverpool500 enrolled4 locationsACTRN12619001597189